ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Preoperative Dual Antiplatelet Therapy Increases Bleeding and Transfusions but Not Mortality in Acute Aortic Dissection Type A Repair

Friday, August 2, 2019

Submitted by

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Author(s)

Emma C Hansson, Arnar Geirsson, Vibeke Hjortdal, Ari Mennander, Christian Olsson, Jarmo Gunn, Igor Zindovic, Anders Ahlsson, Shahab Nozohoor, Raphaelle A Chemtob, Aldina Pivodic, Tomas Gudbjartsson, Anders Jeppsson; on behalf of the NORCAAD Collaboration

Hansson and colleagues analyzed the effect of preoperative dual antiplatelet therapy on outcomes for patients undergoing surgery for acute aortic dissection type A. Among 1,141 patients with acute type A dissection, 108 had aspirin and clopidogrel, and 11 had aspirin and ticagrelor. Dual antiplatelet therapy led to more bleeding and more transfusions but not to more deaths. However, major bleeding was associated with higher mortality. The authors conclude that correct diagnosis is important to avoid dual antiplatelet therapy and reduce bleeding complications in patients with type A dissection.

Add comment

Log in or register to post comments